Jennifer Doudna
Showing 1–4 of 4 transcripts.
- The Economist25 min
Gene editing: should you be worried?
James Dale, Isla Mirada, Natalie Kofler, Emmanuelle Charpentier, Jennifer Doudna, Josh Lehrer, Denis Rebrikov, Theresa Blankmeyer-Burke, He Zhongkui, George Church
Recent advancements in CRISPR and gene editing have accelerated scientific capabilities for curing terminal diseases, securing food supplies against extinction events like the banana fungus TR4, and controlling disease vectors, yet these tools introduce significant ethical risks regarding bio-warfare, social inequality, and the potential for designer humans. While regulatory frameworks vary globally between the strict bans in Europe and the more permissive approaches in the US and Japan, controversies persist over transparency in field trials and the morality of germline editing, as highlighted by critiques from bioethicists regarding community consent and the normalization of de-extinction projects. Ultimately, experts warn that without robust, transparent governance to balance rapid innovation with safety, humanity risks undermining public trust while failing to leverage these essential technologies to mitigate climate change and ensure future food security.
- Goldman Sachs16 min
Walter Isaacson, Historian and Author of "The Code Breaker"
Walter Isaacson, Jennifer Doudna, John Rogers
Fueled by the 2020 Nobel Prize win for Jennifer Doudna and Emmanuelle Charpentier, the CRISPR gene-editing revolution has rapidly shifted medical research from observational to interventional capabilities, underpinning critical advancements like mRNA vaccines. While intense scientific rivalry initially drove these breakthroughs, the global pandemic demonstrated that high-stakes competition can coexist with urgent collaboration to prioritize human health over intellectual property. Looking ahead, experts warn that the technology's future must navigate complex ethical boundaries between therapeutic cures and commercial enhancements to prevent the emergence of free-market eugenics.
- Milken Institute55 min
Lunch Program | The Future of Humankind
Al Gore, Jennifer Doudna, Guru Banavar, Eric Schmidt
Four global leaders addressed the future of humanity at a "Future of Humankind" session, with Al Gore detailing climate crises and renewable breakthroughs, Jennifer Doudna explaining CRISPR gene-editing capabilities, Guru Banavar outlining cognitive computing collaborations, and Eric Schmidt advocating for ambitious innovation "moonshots." The panel emphasized that despite uncertainties, actionable solutions in sustainability, genetic medicine, and artificial intelligence require collaborative efforts between governments, industries, and individuals. By shifting focus from fear to proactive implementation, the speakers argued that these technologies can drive a sustainable future where human intelligence is augmented by machine capabilities to solve critical global challenges.
- Milken Institute52 min
The Future of Humankind feat. Al Gore, Jennifer Doudna, Guruduth Banavar, Eric Schmidt
Al Gore, Jennifer Doudna, Guruduth Banavar, Eric Schmidt
Al Gore, Jennifer Doudna, Guru Banavar, and Eric Schmidt presented a comprehensive overview of existential climate risks, the transformative potential of CRISPR genome editing, and the synergistic roles of cognitive computing and moonshot innovation. Gore detailed the immediate economic and geopolitical threats posed by fossil fuel dependence and heat accumulation, while Doudna explained how CRISPR-Cas9 functions as a programmable tool for precise genetic modification alongside emerging ethical imperatives. Banavar and Schmidt further argued that AI-driven cognitive platforms and radical technological shifts in energy, transportation, and medicine are essential to solving these global challenges and augmenting human intelligence.